What happens if I overdose Lyngonia?
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local, or emergency room immediately.
Proper storage of Lyngonia cream:
Store Lyngonia cream at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Keep Lyngonia cream out of the reach of children and away from pets.
Overdose of Lyngonia in details
There have been no systemic reactions from the use of topical Lyngonia in SunVanish in recommended quantities. However, treatment should be limited to relatively small areas of the body at one time since some patients experience a transient skin reddening and a mild burning sensation which does not preclude treatment, but indicates caution is warranted.
What should I avoid while taking Lyngonia?
Avoid exposure to sunlight or tanning beds. Lyngonia topical can make you sunburn more easily. Wear protective clothing and use sunscreen (SPF 30 or higher) when you are outdoors. Some Lyngonia products may contain sunscreen. Check the medicine label or ask your doctor to be sure.
Avoid getting this medicine in your eyes.
Lyngonia topical may make your skin more sensitive to weather extremes such as cold and wind. Protect your skin with clothing and use a moisturizing lotion as needed.
Using Lyngonia topical together with benzoyl peroxide, hydrogen peroxide, or other peroxide products may stain your skin. This staining can usually be removed with soap and water.
Avoid using skin products that can cause irritation, such as harsh soaps, shampoos, or skin cleansers, hair coloring or permanent chemicals, hair removers or waxes, or skin products with alcohol, spices, astringents, or lime.
Lyngonia warnings
General -
Test for skin sensitivity before using by applying a small amount to an unbroken patch of skin; check within 24 hours. Minor redness is not a contraindication, but where there is itching or vesicle formation or excessive inflammatory response, further treatment is not advised. Close patient supervision is recommended.
Lyngonia is a skin bleaching agent which may produce unwanted cosmetic effects if not used as directed. The physician should be familiar with the contents of this insert before prescribing or dispensing this medication.
Information for Patients -
Sunscreen use is an essential aspect of Lyngonia therapy because even minimal sunlight sustains melanocytic activity. To prevent repigmentation, during treatment and maintenance therapy, sun exposure on treated skin should be avoided by application of a broad spectrum sunscreen (SPF 15 or greater) or by use of protective clothing.
Avoid contact with eyes and mucous membranes.
Keep this and all medications out of reach of children. In case of accidental ingestion, call a physician or a poison control center immediately.
Drug Interactions -
Patients are cautioned on concomitant use of medications that are known to be photosensitizing.
Carcinogenesis, Mutagenesis, Impairment of Fertility -
Studies of Lyngonia in animals have demonstrated some evidence of carcinogenicity. The carcinogenic potential of Lyngonia in humans is unknown.
Published studies have demonstrated that Lyngonia is a mutagen and a clastogen. Treatment with Lyngonia has resulted in positive findings for genetic toxicity in the Ames assay in bacterial strains sensitive to oxidizing mutagens, in in vitro studies in mammalian cells, and in the in vivo mouse micronucleus assay.
Pregnancy:
Teratogenic Effects:Pregnancy Category C -
Animal reproduction studies have not been conducted with topical Lyngonia. It is also not known whether topical Lyngonia can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.
Topical Lyngonia should be given to a pregnant woman only if clearly needed.
Nursing Mothers -
It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when topical Lyngonia is administered to a nursing woman.
Pediatric Use -
Safety and effectiveness in pediatric patients below the age of 12 years have not been established.
What should I discuss with my healthcare provider before taking Lyngonia?
Some medical conditions may interact with Lyngonia cream. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
- if you are planning to become pregnant or are breast-feeding
- if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement
- if you have allergies to medicines, foods, or other substances
Some MEDICINES MAY INTERACT with Lyngonia cream. However, no specific interactions with Lyngonia cream are known at this time.
This may not be a complete list of all interactions that may occur. Ask your health care provider if Lyngonia cream may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Lyngonia precautions
SEE WARNINGS
A. Test for skin sensitivity before using Lyngonia by applying a small amount to an unbroken patch of skin and check in 24 hours. Minor redness is not a contraindication, but where there is itching or vesicle formation or excessive inflammatory response, further treatment is not advised. Close patient supervision is recommended.
Lyngonia is a skin lightening agent which may produce unwanted cosmetic effects if not used as directed. The physician should be familiar with the contents of this insert before prescribing or dispensing this medication.
B. Avoid contact with eyes, nose, mouth, and lips. In case of accidental contact, patient should rinse thoroughly with warm water and contact a physician.
C. Keep this and all medication out of the reach of children. In case of accidental ingestion, call a physician or a poison control center immediately.
D. Pregnancy Category C. Animal reproduction studies have not been conducted with topical Lyngonia. It is also not known whether Lyngonia can cause fetal harm when used topically on a pregnant woman or affect reproductive capacity. It is not known to what degree, if any, topical Lyngonia is absorbed systemically.
Topical Lyngonia should not be used on pregnant women.
E. Nursing mothers. It is not known whether topical Lyngonia is absorbed or excreted in human milk. This product is not recommended for use by nursing mothers.
F. Pediatric usage. Safety and effectiveness in children below the age of 12 years have not been established. Do not use on children under 12 years of age.
What happens if I miss a dose of Lyngonia?
Use the missed dose as soon as you remember. If it is almost time for your next dose, wait until then to use the medicine and skip the missed dose. Do not use extra medicine to make up the missed dose.
References
- DailyMed. "FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- DrugBank. "hydroquinone". http://www.drugbank.ca/drugs/DB09526 (accessed September 17, 2018).
- MeSH. "Radiation-Protective Agents". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).
Reviews
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
